Assenagon Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
309,691
-235,876
| -43% | -$1.5M | ﹤0.01% | 751 |
|
|
2025
Q1 | $2.65M | Sell |
545,567
-220,970
| -29% | -$1.07M | ﹤0.01% | 661 |
|
|
2024
Q4 | $7.33M | Buy |
766,537
+24,985
| +3% | +$239K | 0.01% | 570 |
|
|
2024
Q3 | $6.19M | Buy |
741,552
+316,700
| +75% | +$2.64M | 0.01% | 632 |
|
|
2024
Q2 | $2.9M | Sell |
424,852
-414,562
| -49% | -$2.83M | 0.01% | 766 |
|
|
2024
Q1 | $2.12M | Buy |
839,414
+5,042
| +0.6% | +$12.8K | 0.01% | 851 |
|
|
2023
Q4 | $2M | Buy |
834,372
+651,480
| +356% | +$1.56M | 0.01% | 901 |
|
|
2023
Q3 | $622K | Buy |
182,892
+87,654
| +92% | +$298K | ﹤0.01% | 1121 |
|
|
2023
Q2 | $700K | Buy |
+95,238
| New | +$700K | ﹤0.01% | 1018 |
|
|
2023
Q1 | – | Sell |
-59,007
| Closed | -$697K | – | 1391 |
|
|
2022
Q4 | $697K | Buy |
59,007
+14,645
| +33% | +$173K | ﹤0.01% | 1067 |
|
|
2022
Q3 | $931K | Sell |
44,362
-94,954
| -68% | -$1.99M | ﹤0.01% | 921 |
|
|
2022
Q2 | $4.32M | Buy |
139,316
+80,223
| +136% | +$2.49M | 0.02% | 566 |
|
|
2022
Q1 | $2.43M | Sell |
59,093
-92,330
| -61% | -$3.79M | 0.01% | 728 |
|
|
2021
Q4 | $6.58M | Buy |
151,423
+116,297
| +331% | +$5.06M | 0.02% | 413 |
|
|
2021
Q3 | $1.76M | Buy |
35,126
+8,832
| +34% | +$442K | 0.01% | 707 |
|
|
2021
Q2 | $1.66M | Buy |
+26,294
| New | +$1.66M | 0.01% | 714 |
|
|
2020
Q4 | – | Sell |
-19,600
| Closed | -$2.03M | – | 1032 |
|
|
2020
Q3 | $2.03M | Buy |
+19,600
| New | +$2.03M | 0.01% | 549 |
|
|
2019
Q4 | – | Sell |
-15,810
| Closed | -$827K | – | 771 |
|
|
2019
Q3 | $827K | Buy |
+15,810
| New | +$827K | 0.01% | 553 |
|
|
2019
Q1 | – | Sell |
-24,443
| Closed | -$1.45M | – | 939 |
|
|
2018
Q4 | $1.45M | Buy |
+24,443
| New | +$1.45M | 0.02% | 509 |
|